Resveratrol ameliorates diabetes-related metabolic changes via activation of AMP-activated protein kinase and its downstream targets in db/db mice. (Q54503107)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Resveratrol ameliorates diabetes-related metabolic changes via activation of AMP-activated protein kinase and its downstream targets in db/db mice.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22715031

Resveratrol ameliorates diabetes-related metabolic changes via activation of AMP-activated protein kinase and its downstream targets in db/db mice. (English)

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22715031

author name string

Gyeong-Min Do

1

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22715031

Un Ju Jung

2

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22715031

Hae-Jin Park

3

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22715031

Eun-Young Kwon

4

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22715031

Seon-Min Jeon

5

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22715031

Robin A McGregor

6

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22715031

Myung-Sook Choi

7

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22715031

publication date

20 June 2012

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22715031

Molecular Nutrition and Food Research

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22715031

56

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22715031

8

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22715031

1282-1291

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22715031

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

From mice to men: insights into the insulin resistance syndromes

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

Insulin signal transduction in human skeletal muscle: identifying the defects in Type II diabetes

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

Resveratrol: a relevant pharmacological approach for the treatment of metabolic syndrome?

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

Stimulation of muscle cell glucose uptake by resveratrol through sirtuins and AMPK.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

Activation of estrogen receptor is crucial for resveratrol-stimulating muscular glucose uptake via both insulin-dependent and -independent pathways

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

Resveratrol improves insulin signaling in a tissue-specific manner under insulin-resistant conditions only: in vitro and in vivo experiments in rodents

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

Anti-diabetic effects of resveratrol.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

Finding a target for resveratrol

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

Sensing of energy and nutrients by AMP-activated protein kinase.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor alpha in mice

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

Hypoglycemic effect of resveratrol in type 2 diabetic model db/db mice and its actions in cultured L6 myotubes and RIN-5F pancreatic β-cells

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic beta-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

Combretastatin A-4 activates AMP-activated protein kinase and improves glucose metabolism in db/db mice

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

The use of animal models in diabetes research

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

Long-term adaptation of global transcription and metabolism in the liver of high-fat diet-fed C57BL/6J mice

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

Resveratrol bioavailability and toxicity in humans

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

Resveratrol and health--a comprehensive review of human clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

Glycogen-dependent effects of 5-aminoimidazole-4-carboxamide (AICA)-riboside on AMP-activated protein kinase and glycogen synthase activities in rat skeletal muscle

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

Effect of curcumin supplementation on blood glucose, plasma insulin, and glucose homeostasis related enzyme activities in diabetic db/db mice

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

Phosphoenolpyruvate carboxykinase is necessary for the integration of hepatic energy metabolism

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

The Anti-Obesity Effect of the Palatinose-Based Formula Inslow is Likely due to an Increase in the Hepatic PPAR-alpha and Adipocyte PPAR-gamma Gene Expressions

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

Mechanism for peroxisome proliferator-activated receptor-alpha activator-induced up-regulation of UCP2 mRNA in rodent hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

Adiponectin suppresses gluconeogenic gene expression in mouse hepatocytes independent of LKB1-AMPK signaling

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200067

21 January 2018

Identifiers

10.1002/MNFR.201200067

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22715031

1 reference

Europe PubMed Central

30 May 2018

http://europepmc.org/abstract/MED/22715031

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54503107&oldid=1468978260"